As of June 2026, 143 paid clinical trials are recruiting for Oncology in Hackensack, New Jersey. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Hackensack has approximately 332 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Hackensack, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hackensack University Medical Center | Neuroblastoma, Advanced Solid Tumor, Heart Failure | 135 |
| John Theurer Cancer Center at Hackensack University Medical Center | Leukemia, Myeloid, Acute, Acute Myeloid Leukemia, Advanced Solid Tumors | 42 |
| John Theurer Cancer Center | Melanoma, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer | 16 |
| Hackensack Meridian Health | Acute Myocardial Infarction (AMI), Atrial Fibrillation, Breast Cancer | 11 |
| Northeast Regional Epilepsy Group | Dravet Syndrome, Focal Onset Seizures, KCNT1-Related Epilepsy | 8 |
| John Theurer Cancer Center at Hackensack UMC | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Lung Cancer | 7 |
| John Theurer Cancer Center Hackensack University Medical Center | Advanced Solid Tumor, Advanced Solid Tumors, Chronic Lymphocytic Leukemia | 6 |
| Hackensack Meridian Health (Data collection only) | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma, High Grade B Cell Lymphoma | 4 |
| Hackensack Meridian Health - Hackensack University Medical Center | Plasma Cell Myeloma Refractory, Hemophilia, Glycogen Storage Disease Type II | 4 |
| NEREG | Focal Epilepsy | 3 |
| Praxis Research Site | Developmental and Epileptic Encephalopathy 1, Focal Onset Seizure, Focal Seizure | 3 |
| HMH Hackensack University Medical Center | Clostridioides Difficile Associated Disease, Stroke, Acute | 2 |
| Hackensack Medical Center | Acute Myeloid Leukemia, Alzheimer Disease, Chronic Myelomonocytic Leukemia | 2 |
| Hackensack Univeristy Medical Center | Pre-Term, Premature, Respiratory Distress Syndrome in Premature Infant | 2 |
| Hackensack University Medical Center - John Theurer Cancer Center | Endometrial Cancer, Non-squamous EGFR Wt NSCLC, Ovarian Cancer | 2 |
| John Theurer Cancer Center-Hackensack | Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Merkel Cell Carcinoma | 2 |
| Joseph M. Sanzari Children's Hospital | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 2 |
| Investigative | Solid Tumors, Hidradenitis Suppurativa (HS) | 2 |
| Amanda Khoudary | Lung Cancer | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Clinical Trial Site | Cerebral Amyloid Angiopathy | 1 |
| Context Investigational Site | Cholangiocarcinoma Advanced, Cholangiocarcinoma Non-resectable, Colorectal Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Gastroenterology Associates of New Jersey | Colo-rectal Cancer | 1 |
Recruiting trials in Hackensack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Hackensack from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 332 recruiting clinical trials in Hackensack, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Hackensack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Hackensack include Advanced Solid Tumor (11), Acute Myeloid Leukemia (10), Advanced Solid Tumors (9), Breast Cancer (9), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hackensack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Hackensack include Hackensack University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, John Theurer Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Hackensack are Cancer & tumors (183), Neurology & pain (15), Cardiovascular (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.